Once again our elected representatives have done the wrong thing.
Those who know me will recall that I spent the majority of my work career in clinical cancer research.
In recent memory, I don’t recall any the government’s involvement in any part of delivering health care to the people being done better than the private sector.
A clean desk is the sign of a sick mind.
The last thing we would want from a safety standpoint is to grant “BigPharma,” to control the FDA.
Perhaps those involved forgot the abortive attempt to do so-called Obama Care.
The full bill is a massive 824 pages long; so reading the whole thing in as short period of time is not feasible.
Just like Obama’s Health Care Denial and Rationing Plan, legislators had to pass the bill to find out what was in it.
Stop the cameras !!! There are 325+ million Americans alive and living today. (Source) Toby just told us above that because of ObamaCare 20 million people are enrolled in this boondoggle, something he did not expect us to catch.
Today, the Senate passed the 21st Century Cures Act, a bill designed to weaken the FDA and empower pharmaceutical companies, sending it to President Obama’s desk.
For all its flaws, the bill’s passage was inevitable.
Obama signed a major biomedical legislation into law today that gives billions of dollars to medical research and aims to speed up the development of new drugs and devices.
The 21st Century Cures Act provides $6.3 billion in funding for medical research stretched out over a decade.
Included in that is $1 billion to fight opioid abuse.
About $4.8 billion will go to the National Institutes of Health, with money also going to the president’s precision medicine initiative and an initiative to help cure brain disorders such as Alzheimer’s disease and epilepsy.
Obama pointed out during a White House signing ceremony Tuesday afternoon that the bill received wide bipartisan support.
“I think it indicates the power of this issue and how deeply it touches every family across America,” he said.
There’s no way Obama wouldn’t sign it, as it contained provisions funding his Precision Medicine Initiative, and he supported it all along.
For all its flaws, I knew the bill’s passage was inevitable since after the election when Senate Majority Leader Mitch McConnell stated that the bill was a priority.
After all, 21st Century Cures Act funds the “Cancer Moonshot” initiative.
I thought there were some good provisions in it, such as increasing funding for the NIH, but that it had a fatal flaw—several, actually.
However, those fatal flaws derived from the idea that, if we only relax the “stifling” regulations of the FDA that, if you believe proponents of the bill that has just become law, the magic of the free market would unleash the creativity of private industry and academia to open the spigot and let the cures to all sorts of diseases flow.
See the entire article below.
The bill didn’t go very far in 2015, but by summer 2016 it was still around, still containing the same flaws, still being pushed by the same characters.
The FDA is too strict, that its “out of control” regulations are hampering medical innovation and slowing drug approval unduly while (of course) people are dying in droves waiting for the cures that government is keeping from the people, is simply not true.
The central premise of the bill is ideological nonsense.
It turns out that radical reform involving weakening the FDA is not needed.
In fact, the FDA, despite being underfunded, is actually remarkably efficient at new drug approvals, evaluating nearly all new drug applications within 6 to 10 months, an impressive turnaround for such complex assessments.
It’s been pointed out that the FDA actually acts more rapidly than most European regulatory agencies.
Basically, there is no evidence that the FDA hampers overall medical innovation, nor is there evidence that the FDA’s current requirements lead to higher drug prices or cost lives.
None of that stopped passage of the bill.
Unfortunately, the argument fooled a lot of people, including, to its utter shame, the American Society of Clinical Oncology (ASCO), which urged passage.